Latebreakers: Once daily PAH drug OK'd

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The drug is also approved to treat schizophrenia and bipolar depression.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

Check out these important FDA updates from the month of October 2024.